Directed differentiation of human induced pluripotent stem cells into midbrain.
10.12122/j.issn.1673-4254.2023.02.03
- Author:
Jia Jia XU
1
;
Yang Yang LI
1
;
Guang Shang ZHONG
2
;
Zhu Ling FANG
2
;
Chun Bo LIU
1
;
Cai Yun MA
1
;
Chun Jing WANG
1
;
Yu GUO
2
;
Chang Qing LIU
1
Author Information
1. School of Life Sciences, Bengbu Medical College, Bengbu 233000, China.
2. School of Laboratory Medicine, Bengbu Medical College, Bengbu 233000, China.
- Publication Type:Journal Article
- Keywords:
Parkinson's disease;
cell transplantation;
dopaminergic progenitor cells;
human induced pluripotent stem cells;
primitive neuroepithelial cells;
rat models
- MeSH:
Humans;
Rats;
Animals;
Induced Pluripotent Stem Cells;
Cell Differentiation/physiology*;
Neurons;
Parkinson Disease;
Mesencephalon;
Cells, Cultured
- From:
Journal of Southern Medical University
2023;43(2):175-182
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To establish an efficient protocol for directed differentiation of human induced pluripotent stem cells (hiPSCs) into functional midbrain dopaminergic progenitor cells (DAPs) in vitro.
METHODS:hiPSCs were induced to differentiate into DAPs in two developmental stages. In the first stage (the first 13 days), hiPSCs were induced into intermediate cells morphologically similar to primitive neuroepithelial cells (NECs) in neural induction medium containing a combination of small molecule compounds. In the second stage, the intermediate cells were further induced in neural differentiation medium until day 28 to obtain DAPs. After CM-DiI staining, the induced DAPs were stereotactically transplanted into the right medial forebrain bundle (MFB) of rat models of Parkinson's disease (PD). Eight weeks after transplantation, the motor behaviors of PD rats was evaluated. Immunofluorescence assay of brain sections of the rats was performed at 2 weeks after transplantation to observe the survival, migration and differentiation of the transplanted cells in the host brain microenvironment.
RESULTS:hiPSCs passaged stably on Matrigel showed a normal diploid karyotype, expressed the pluripotency markers OCT4, SOX2, and Nanog, and were positive for alkaline phosphatase. The primitive neuroepithelial cells obtained on day 13 formed dense cell colonies in the form of neural rosettes and expressed the neuroepithelial markers (SOX2, Nestin, and PAX6, 91.3%-92.8%). The DAPs on day 28 highly expressed the specific markers (TH, FOXA2, LMX1A and NURR1, 93.3-96.7%). In rat models of PD, the hiPSCs-DAPs survived and differentiated into TH+, FOXA2+ and Tuj1+ neurons at 2 weeks after transplantation. Eight weeks after transplantation, the motor function of PD rats was significantly improved as shown by water maze test (P < 0.0001) and apomorphine-induced rotation test (P < 0.0001) compared with rats receiving vehicle injection.
CONCLUSION:HiPSCs can be effectively induced to differentiate into DAPs capable of differentiating into functional neurons both in vivo and in vitro. In rat models of PD, the transplanted hiPSCs-DAPs can survive for more than 8 weeks in the MFB and differentiate into multiple functional neurocytes to ameliorate neurological deficits of the rats, suggesting the potential value of hiPSCs-DAPs transplantation for treatment of neurological diseases.
